Specific deletion of TRAF3 in B lymphocytes leads to B-lymphoma development in mice

This publication has 15 references indexed in Scilit:

• Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33)
  Leukemia, 2009
• Autoimmune disorders and lymphoma
  Annals of Oncology, 2008
• TRAF2 and TRAF3 Signal Adapters Act Cooperatively to Control the Maturation and Survival Signals Delivered to B Cells by the BAFF Receptor
  Immunity, 2008
• Tumor Necrosis Factor Receptor-Associated Factor 3 Is a Critical Regulator of B Cell Homeostasis in Secondary Lymphoid Organs
  Immunity, 2007
• Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma
  Cancer Cell, 2007
• Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
  Cancer Cell, 2007
• Oridonin, a diterpenoid purified fromRabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-κB signal pathways
  Molecular Cancer Therapeutics, 2005
• The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers
  Current Opinion in Pharmacology, 2004
• The Bcl-2 family: roles in cell survival and oncogenesis
  Oncogene, 2003
• Bethesda proposals for classification of lymphoid neoplasms in mice
  Blood, 2002